tirzepatide ophthalmic side effects What ODs Need to Know About GLP-1 Drugs Ophthalmic Complications Associated With The

In another notable case, a 36-year-old woman with depression and binge-eating disorder experienced a dramatic improvement in her PHQ-9 score, dropping from 14 to 1, alongside nearly 50 pounds of weight loss over five months on tirzepatide (titrated to 7.5 mg)

Side effects are broadly similar, with tirzepatide more often linked to nausea and vomiting, and semaglutide more to constipation and reflux

A C20 fatty diacid moiety is attached via a hydrophilic linker (-glutamyl-2x-aminoethoxyethoxyacetyl) at lysine 20, promoting albumin binding and extending its duration in the body

Most researchers who make it through the initial escalation period find long-term side effects manageable

These benefits stem from tirzepatide dual GIP/GLP-1 mechanism affecting receptors throughout the body